Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.

Two different responses to the therapy were observed in a group of patients receiving the protease inhibitor indinavir. In one, suppression of virus replication occurred and has persisted for 90 weeks (bDNA, < 500 human immunodeficiency virus type 1 [HIV-1] RNA copies/ml). In the second group, a reb...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Zhang, Y M, Imamichi, H, Imamichi, T, Lane, H C, Falloon, J, Vasudevachari, M B, Salzman, N P
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1997
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191944/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9261388/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.9.6662-6670.1997
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!